SolarWindow Technologies, Inc. (WNDW)

[TRUISM]

RCAR got bit with the same caveat emptor designation as well as WNDW. Probably not a coincidence that Harmel Ryat is behind them both. Both took a mirrored plunge today.

UNDER SURVEILLANCE-EXCERPT

RenovaCare (RCAR): Dancing With Deception
by Sonya Colberg, Senior Editor - 2/21/2018
Click For Link



Today, the company released “news” that a patent dispute has been settled. A naïve market bought into this nonsense and pushed the stock to 5-year record levels exceeding $10. The stock market valuation is now teetering on $750 million … for a company with nothing but a pretty story surrounding its sole, experimental product which has not been submitted to the FDA for approval.

RenovaCare doesn’t tell investors the truth.

So we will.

*1 Nothing Like “Old” News

Today’s company headline screams “RenovaCare Secures Patent Victory…”

Yippee, right?

But … on Dec. 18, 2017 … a Final Written Decision was issued by the US Patent Office, resolving the patent dispute.

The decision date is right there in RenovaCare’s own SEC filing.

Now, desperate RenovaCare has issued a statement that claims “patent victory.”

Notice also that RenovaCare doesn’t dare enter this press release into its SEC filings. That would invite closer regulatory scrutiny.

RenovaCare, in our opinion, has probably committed fraud. At best it is deceiving people with 3-month-old information dressed up as news.

*2. The Motivation

What’s behind today’s shenanigans?

Well, the motivation is clear.

RenovaCare's SEC filing that contains the patent decision date is the S-1.

This Feb. 12, 2018 document sets up insiders to unload millions of shares of their cheap stock.

So obviously, RenovaCare wants to put on a good show so insiders can sell into the inflated stock price.

*3. More Out-Right Deception

Yesterday, Feb. 20, small investors breathed a sigh of relief.

But RenovaCare had just duped non-insiders.

The company filed a deceptive filing with the golden words that its biggest stockholder, Harmel Rayat’s Kalen Capital, had “requested the withdrawal of the 10,500,000 registered for resale…”



"The Company has determined that all shares required to be registered on behalf of Jörg Gerlach, MD PhD. may now be sold without restriction under Rule 144 as promulgated under the Securities Act of 1933, as amended; and, Kalen Capital Corporation has requested the withdrawal of the 10,500,000 registered for resale on its behalf none of which have been sold as of the date hereof."



Everyone thought that the controlling owner had changed his mind and wouldn’t soon be unloading stock with the rest of them.

Whew, right?

Wrong.

This is absolutely misleading. The 10.5 million shares mentioned in the filing were registered for resale on Mr. Rayat’s behalf back in 2014

Blessings to All

TRUTH